Simultaneous multi-vessel subacute stent thromboses in zotarolimus-eluting stents.
Despite its low incidence, stent thrombosis (ST) is one of the most dreaded complications of percutaneous coronary intervention. Endeavor (Medtronics Europe SA) is a new zotarolimus-eluting stent (ZES) with a favorable safety profile that was reported in early and ongoing trials. However, few lethal stent thromboses related to this new drug eluting stent (DES) have been reported. We experienced a case of simultaneous subacute ZES thromboses, 6 days after stent implantations in the proximal left anterior descending artery and the proximal right coronary artery (RCA).
Kim
Yong-Hyun
YH
Cardiovascular Center, Korea University Ansan Hospital, Ansan, Korea.
Suh
Soon Yong
SY
Kim
Seong Hwan
SH
Lim
Sang-Yup
SY
Roh
Seung-Young
SY
Kim
Ji-Bak
JB
Song
Woo Hyuk
WH
Ahn
Jeong Cheon
JC